Infosys Ltd, a global leader in IT services, has finalized the sale of a 2% stake in its Japan-based joint venture, HIPUS, to Mitsubishi Heavy Industries (MHI), strengthening ties between the two companies. The transaction, completed on May 14, 2025, ahead of the anticipated Q1 FY26 timeline, follows MHI’s entry as a strategic investor in HIPUS, announced on April 17, 2025. HIPUS, established in 2019, specializes in providing end-to-end procurement solutions for Japanese corporations, utilizing advanced digital platforms and sourcing expertise. Infosys, which held a majority stake in the venture, has now transferred a portion to MHI, a long-term client and one of the world’s leading industrial groups with operations in energy, infrastructure, machinery, aerospace, and defense.
The stake sale aims to deepen collaboration between Infosys and MHI, unlocking new business opportunities in Japan’s competitive market. “This strategic investment by MHI reinforces our commitment to delivering next-generation digital solutions to Japanese enterprises,” an Infosys spokesperson said.
The deal, subject to standard closing conditions, marks a significant step in Infosys’ efforts to expand its footprint in Japan while fostering innovation through strategic partnerships.
The stake sale aims to deepen collaboration between Infosys and MHI, unlocking new business opportunities in Japan’s competitive market. “This strategic investment by MHI reinforces our commitment to delivering next-generation digital solutions to Japanese enterprises,” an Infosys spokesperson said.
The deal, subject to standard closing conditions, marks a significant step in Infosys’ efforts to expand its footprint in Japan while fostering innovation through strategic partnerships.
You may also like
Govt withdraws security nod to Turkish handler at 9 airports
Hit-and-run driver mows down football fans at Espanyol vs Barcelona as game stopped
Piers Morgan exposes awkward moment Elon Musk queued to speak to Donald Trump
Man in Gurugram saves three lives by donating organs
Adanis terminate deal with Chinese company DragonPass